Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-02-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA has approved a supplemental application for NOVOLOG (insulin aspart) from Novo Nordisk. The approval relates to changes to the produ…
-
FDA approval · 2015-02-25FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-02-25FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2015-02-25FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly, expanding the approved formulation…
-
FDA approval · 2015-02-25FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes [Phase 1]
This update reports the completion of a Phase 1 bioequivalence trial comparing NN1045 and NN5401 in adults with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes [Phase 1]
This document reports the completion of a Phase 1 clinical trial assessing the pharmacokinetic properties of NN1218 formulations in subjects…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1 [Phase 1]
This ClinicalTrials.gov entry documents the completion of a Phase 1 pharmacokinetic study of NN1218 in subjects with Type 1 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein [Phase 1, Phase 2]
Phase 1/2 trial evaluating catheter-based islet transplantation via the umbilical vein for Type 1 diabetes has completed.
-
CLINICAL_TRIALS research · 2015-02-19Clinical Trial Update: Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options [NA]
A clinical trial update examining postprandial glucose control and gastric emptying in Type 1 diabetes, focusing on pathogenetic factors and…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and Efficacy [NA]
A completed clinical trial assessing an Internet-based cognitive-behavioral intervention for youth with Type 1 diabetes mellitus, reporting …
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the effects of vitamins C and E on endothelial function in adolescents with Type 1 diabetes mellitus has…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of CBX129801 in patients with Type 1 diabetes and diabetic peripheral neuropathy; the s…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients [NA]
A telematic program for optimization of metabolic control in patients with Type 1 diabetes has completed its clinical evaluation.
-
FDA approval · 2015-01-26FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, including the associated diluent as part of the approved product.
-
FDA approval · 2015-01-23FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk, expanding the product’s regulatory authorization…
-
FDA approval · 2015-01-23FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in changes to the product labeling as…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Diabetes Visual Function Supplement Study [NA]
The Diabetes Visual Function Supplement Study sponsored by ZeaVision has completed, evaluating its effects in individuals with Type 1 or Typ…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: A Research Trial of Aralast in New Onset Diabetes (RETAIN) [Phase 1]
A Phase 1 trial evaluating Aralast for new-onset Type 1 diabetes was terminated, with results posted in January 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM [NA]
This clinical trial update examines a strategy combining basal-bolus insulin with post-exercise carbohydrate feeding in people with Type 1 D…
-
FDA approval · 2015-01-14FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. This action represents a supplemental approval, li…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Effect of CSII and CGM on Progression of Late Diabetic Complications [Phase 4]
A Phase 4 trial evaluated whether insulin pump therapy (CSII) combined with continuous glucose monitoring (CGM) affects the progression of l…
-
FDA approval · 2015-01-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. This action confirms approval of a supplem…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) [Phase 3]
The PREVENTKD Phase 3 trial in type 1 diabetes mellitus was terminated and results were posted in January 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Inducing Remission in Type 1 Diabetes With Alefacept [Phase 2]
A Phase 2 trial of alefacept for inducing remission in new-onset type 1 diabetes was terminated, with results posted.